• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有强效癌细胞细胞毒性的有机金属钌芳配合物。

Organometallic osmium arene complexes with potent cancer cell cytotoxicity.

机构信息

Department of Chemistry, University of Warwick, Gibbet Hill Road, Coventry, CV4 7AL, UK.

出版信息

J Med Chem. 2010 Nov 25;53(22):8192-6. doi: 10.1021/jm100560f. Epub 2010 Oct 26.

DOI:10.1021/jm100560f
PMID:20977192
Abstract

Iodido osmium(II) complexes Os(η(6)-arene)(XY)I (XY = p-hydroxy or p-dimethylaminophenylazopyridine, arene = p-cymene or biphenyl) are potently cytotoxic at nanomolar concentrations toward a panel of human cancer cell lines; e.g., IC(50) = 140 nM for Os(η(6)-bip)(azpy-NMe(2))I toward A2780 ovarian cancer cells. They exhibit low toxicity and negligible deleterious effects in a colon cancer xenograft model, giving rise to the possibility of a broad therapeutic window. The most active complexes are stable and inert toward aquation. Their cytotoxic activity appears to involve redox mechanisms.

摘要

碘代锇(II)配合物Os(η(6)-芳烃)(XY)I(XY = 对羟基或对二甲氨基苯偶氮吡啶,芳烃 = 对伞花烃或联苯)在纳摩尔浓度下对一系列人类癌细胞系具有很强的细胞毒性;例如,Os(η(6)-联苯)(azpy-NMe(2))I对 A2780 卵巢癌细胞的 IC(50)为 140 nM。它们在结肠癌异种移植模型中表现出低毒性和可忽略的有害影响,这为广泛的治疗窗提供了可能性。最活跃的配合物是稳定和惰性的水合。它们的细胞毒性活性似乎涉及氧化还原机制。

相似文献

1
Organometallic osmium arene complexes with potent cancer cell cytotoxicity.具有强效癌细胞细胞毒性的有机金属钌芳配合物。
J Med Chem. 2010 Nov 25;53(22):8192-6. doi: 10.1021/jm100560f. Epub 2010 Oct 26.
2
Structure-activity relationships for osmium(II) arene phenylazopyridine anticancer complexes functionalised with alkoxy and glycolic substituents.具有烷氧基和羟基取代基的锇(II)芳基苯偶氮吡啶抗癌配合物的构效关系。
J Inorg Biochem. 2020 Sep;210:111154. doi: 10.1016/j.jinorgbio.2020.111154. Epub 2020 Jun 24.
3
Chloro half-sandwich osmium(II) complexes: influence of chelated N,N-ligands on hydrolysis, guanine binding, and cytotoxicity.氯半夹心钌(II)配合物:螯合的N,N-配体对水解、鸟嘌呤结合及细胞毒性的影响。
Inorg Chem. 2007 May 14;46(10):4049-59. doi: 10.1021/ic062350d. Epub 2007 Apr 19.
4
Tuning the reactivity of osmium(II) and ruthenium(II) arene complexes under physiological conditions.在生理条件下调节锇(II)和钌(II)芳烃配合物的反应活性。
J Am Chem Soc. 2006 Feb 8;128(5):1739-48. doi: 10.1021/ja055886r.
5
Structure-activity relationships for organometallic osmium arene phenylazopyridine complexes with potent anticancer activity.具有强效抗癌活性的金属有机锇芳基苯并偶氮吡啶配合物的构效关系。
Dalton Trans. 2011 Oct 28;40(40):10553-62. doi: 10.1039/c1dt10937e. Epub 2011 Aug 22.
6
Tuning the hydrolytic aqueous chemistry of osmium arene complexes with N,O-chelating ligands to achieve cancer cell cytotoxicity.通过 N,O-螯合配体调节锇芳烃配合物的水解水相化学以实现癌细胞毒性。
J Am Chem Soc. 2007 Mar 21;129(11):3348-57. doi: 10.1021/ja068335p. Epub 2007 Feb 24.
7
Phenylazo-pyridine and phenylazo-pyrazole chlorido ruthenium(II) arene complexes: arene loss, aquation, and cancer cell cytotoxicity.苯基偶氮吡啶和苯基偶氮吡唑氯钌(II)芳烃配合物:芳烃损失、水合作用及癌细胞细胞毒性
Inorg Chem. 2006 Dec 25;45(26):10882-94. doi: 10.1021/ic061460h.
8
Organometallic osmium(II) arene anticancer complexes containing picolinate derivatives.含吡啶酸盐衍生物的有机金属锇(II)芳族抗癌配合物。
Inorg Chem. 2009 Feb 16;48(4):1753-62. doi: 10.1021/ic8020222.
9
From hydrolytically labile to hydrolytically stable Ru(II)-arene anticancer complexes with carbohydrate-derived co-ligands.具有碳水化合物衍生共配体的从水解不稳定到水解稳定的 Ru(II)-芳环抗癌配合物。
J Inorg Biochem. 2011 Feb;105(2):224-31. doi: 10.1016/j.jinorgbio.2010.10.004. Epub 2010 Oct 14.
10
Osmium(II)--versus ruthenium(II)--arene carbohydrate-based anticancer compounds: similarities and differences.锇(II)——与钌(II)——芳基碳水化合物抗癌化合物:相似与不同。
Dalton Trans. 2010 Aug 21;39(31):7345-52. doi: 10.1039/c003085f. Epub 2010 Jul 2.

引用本文的文献

1
Sidechain structure-activity relationships of cyclobutane-based small molecule αvβ3 antagonists.基于环丁烷的小分子αvβ3拮抗剂的侧链构效关系
RSC Med Chem. 2024 Sep 13;15(10):3616-24. doi: 10.1039/d4md00306c.
2
Cancer 3D Models for Metallodrug Preclinical Testing.癌症金属药物临床前测试的 3D 模型。
Int J Mol Sci. 2023 Jul 25;24(15):11915. doi: 10.3390/ijms241511915.
3
Self-assembled ruthenium and osmium nanosystems display a potent anticancer profile by interfering with metabolic activity.自组装钌和锇纳米系统通过干扰代谢活性展现出强大的抗癌特性。
Inorg Chem Front. 2022 Jun 7;9(11):2594-2607. doi: 10.1039/d2qi00423b. Epub 2022 Apr 12.
4
NMR studies of group 8 metallodrugs: Os-enriched organo-osmium half-sandwich anticancer complex.NMR 研究第 8 族金属药物:富含锇的有机锇半夹心型抗癌配合物。
Dalton Trans. 2021 Sep 28;50(37):12970-12981. doi: 10.1039/d1dt02213j.
5
Osmium(ii) tethered half-sandwich complexes: pH-dependent aqueous speciation and transfer hydrogenation in cells.锇(II)连接的半夹心配合物:细胞中pH依赖性的水相形态及转移氢化作用
Chem Sci. 2021 Jun 10;12(27):9287-9297. doi: 10.1039/d1sc01939b. eCollection 2021 Jul 14.
6
Synthesis, structure and anticancer properties of new biotin- and morpholine-functionalized ruthenium and osmium half-sandwich complexes.新型生物素和吗啉官能化钌与锇半夹心配合物的合成、结构及抗癌性能
J Biol Inorg Chem. 2021 Aug;26(5):535-549. doi: 10.1007/s00775-021-01873-9. Epub 2021 Jun 26.
7
Metallodrugs are unique: opportunities and challenges of discovery and development.金属药物独具特色:发现与开发的机遇与挑战
Chem Sci. 2020 Nov 12;11(48):12888-12917. doi: 10.1039/d0sc04082g.
8
Triazole-based osmium(ii) complexes displaying red/near-IR luminescence: antimicrobial activity and super-resolution imaging.具有红色/近红外发光的基于三唑的锇(II)配合物:抗菌活性和超分辨率成像
Chem Sci. 2020 Aug 7;11(33):8928-8935. doi: 10.1039/d0sc03563g.
9
Osmium-arene complexes with high potency towards Mycobacterium tuberculosis.具有高效抗结核分枝杆菌作用的锇芳烃配合物。
Metallomics. 2021 Apr 8;13(4). doi: 10.1093/mtomcs/mfab007.
10
Dose- and time-dependent tolerability and efficacy of organo-osmium complex FY26 and its tissue pharmacokinetics in hepatocarcinoma-bearing mice.有机锇配合物FY26在荷肝癌小鼠体内的剂量和时间依赖性耐受性、疗效及其组织药代动力学
Metallomics. 2021 Feb 2;13(2). doi: 10.1093/mtomcs/mfaa003.